Latest news
EUSA Pharma Completes Acquisition of Global Rights to SYLVANT® (Siltuximab) and Presents Company Update at 37th J.P. Morgan Healthcare Conference
Read more
We are passionate and committed to make our products globally available to enable patients to live and embrace life
Who we are
We are a dynamic, global biopharmaceutical company focused on oncology and rare disease, committed to bringing innovative medicines to patients.
Therapy Areas
Our therapy areas, which focus on oncology and rare diseases, help make a meaningful difference to patients’ lives.
Careers
We are constantly looking for highly talented individuals who, like us, are passionate and committed to helping patients live and embrace life.